Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group (Q70817454)
Jump to navigation
Jump to search
scientific article published on 01 January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group |
scientific article published on 01 January 1996 |
Statements
Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group (English)